Nabumetone
Product Images NDC 45865-111

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 45865-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nabumetone Tablets 750 mg (Pdp 111)

Nabumetone Tablets 750 mg (Pdp 111)
NABUMETONE is a medication available in the form of tablets with a dose of 750mg. It is marketed under the brand name RELAFEN. The price is not provided in the given text.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
This is a chart showing the plasma concentrations of the active metabolite of Nabumetone at steady state after once-daily dosing of either 1000mg or 2000mg. The chart includes dosage information and time in hours.*
FDA Label Image

Structure1 (Structure1)

FDA Label Image

Structure2 (Structure2)

Structure2 (Structure2)
6-methoxy-2-naphthylacetic acid (SMNA) is a chemical compound with the molecular formula COOH-CHgO.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.